Bio-Techne (TECH) Deferred Taxes (2009 - 2026)
Bio-Techne (TECH) recorded quarterly Deferred Taxes of $2.8 million in Q1 2026, up 4047.22% quarter-over-quarter from -$72000.0 in Q4 2025, and up 152.55% on a YoY basis from $1.1 million in Q1 2025.
Bio-Techne (TECH) Deferred Taxes (2009 - 2026) Analysis & Trends
Bio-Techne's Deferred Taxes history runs 18 years deep, the most recent figure standing at $2.8 million for Q1 2026.
- In Q1 2026, Deferred Taxes rose 152.55% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at -$24.2 million (up 14.59% YoY), while the FY2025 annual figure was -$51.1 million, down 29.56% from the prior year.
- Deferred Taxes was $2.8 million for Q1 2026 at Bio-Techne, up from -$72000.0 in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $5.3 million in Q3 2025 to a low of -$32.3 million in Q2 2025.
- Historically, Deferred Taxes has averaged -$6.6 million across 5 years, with a median of -$5.4 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Deferred Taxes tumbled 2586.41% in 2023, then soared 198.78% in 2025.
- A 5-year view of Deferred Taxes shows it stood at -$1.6 million in 2022, then plunged by 571.03% to -$10.7 million in 2023, then advanced by 24.68% to -$8.1 million in 2024, then soared by 99.11% to -$72000.0 in 2025, then soared by 4047.22% to $2.8 million in 2026.
- The last three Deferred Taxes figures came in at $2.8 million (Q1 2026), -$72000.0 (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | -859,000.00 |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -65.30 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | - |
| 10 | Bio-Techne | 8.41 Bn | 8.20 Bn | 208.29 Mn | 2.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.84 Mn |
| Dec 31, 2025 | -72,000.00 |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | -32.28 Mn |
| Mar 31, 2025 | -5.41 Mn |
| Dec 31, 2024 | -8.08 Mn |
| Sep 30, 2024 | -5.34 Mn |
| Jun 30, 2024 | -9.55 Mn |
| Mar 31, 2024 | -7.58 Mn |
| Dec 31, 2023 | -10.72 Mn |
| Sep 30, 2023 | -11.59 Mn |
| Jun 30, 2023 | -6.92 Mn |
| Mar 31, 2023 | -16.29 Mn |
| Dec 31, 2022 | -1.60 Mn |
| Sep 30, 2022 | -4.77 Mn |
| Jun 30, 2022 | -1.07 Mn |
| Mar 31, 2022 | 655,000.00 |
| Dec 31, 2021 | 1.83 Mn |
| Sep 30, 2021 | 5.41 Mn |
| Jun 30, 2021 | -21.41 Mn |